Zobrazeno 1 - 10
of 50
pro vyhledávání: '"donor specific antibodies (dsa)"'
Autor:
Aylin Akifova, Klemens Budde, Michael Oellerich, Julia Beck, Kirsten Bornemann-Kolatzki, Ekkehard Schütz, Bilgin Osmanodja
Publikováno v:
Transplant International, Vol 37 (2024)
Antibody-mediated rejection (AMR) is a major cause of graft failure limiting long-term graft survival after kidney transplantation. Current diagnostic strategy to detect AMR is suboptimal and requires further improvement. Previously suggested treatme
Externí odkaz:
https://doaj.org/article/c5f5cdb1e10e4bbd8969ac1783f2fef8
Autor:
Jasmin Mucha, Ara Cho, Anna Marianne Weijler, Moritz Muckenhuber, Amun Georg Hofmann, Markus Wahrmann, Andreas Heinzel, Birgit Linhart, Pia Gattinger, Rudolf Valenta, Gabriela Berlakovich, Andreas Zuckermann, Peter Jaksch, Rainer Oberbauer, Thomas Wekerle
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionAntibody mediated rejection (ABMR) is a major factor limiting outcome after organ transplantation. Anti-HLA donor-specific antibodies (DSA) of the IgG isotype are mainly responsible for ABMR. Recently DSA of the IgE isotype were demonstra
Externí odkaz:
https://doaj.org/article/a3b4015904054f629a6b499597c7de57
Autor:
Schneider Daniel, Behrens Stephan, Philipp Jürgen, Eitler Jiri, Stumpf Julian, Tonn Torsten, Sonntag Frank, Hugo Christian, Schmieder Florian
Publikováno v:
Current Directions in Biomedical Engineering, Vol 8, Iss 2, Pp 501-504 (2022)
Antibody-mediated rejection after kidney transplantation is a major limitation for long-term survival of donated kidneys within the recipient allograft. With the existing HLA cross-matching test only complement activating donor specific antibodies ar
Externí odkaz:
https://doaj.org/article/b2126ecedec24c26927878c172b56a17
Autor:
Sakiko Kumata, Takashi Hirama, Yui Watanabe, Hisashi Oishi, Hiromichi Niikawa, Miki Akiba, Jussi Tikkanen, Yoshinori Okada
Publikováno v:
BMC Pulmonary Medicine, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background Anti-human leukocyte antigen (HLA) antibody testing was approved by the Japanese government in 2018. As such, there was no longitudinal data regarding the HLA-sensitization of lung transplant (LTX) patients in Japan. We therefore
Externí odkaz:
https://doaj.org/article/cb1eead47a3f412cbebd8c68ee0c5aac
Autor:
Jakob Mühlbacher, Konstantin Doberer, Nicolas Kozakowski, Heinz Regele, Sümeyra Camovic, Susanne Haindl, Gregor Bond, Helmuth Haslacher, Farsad Eskandary, Jeff Reeve, Georg A. Böhmig, Markus Wahrmann
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Background: Screening for donor-specific antibodies (DSA) has limited diagnostic value in patients with late antibody-mediated rejection (ABMR). Here, we evaluated whether biomarkers reflecting microcirculation inflammation or tissue injury—as an a
Externí odkaz:
https://doaj.org/article/0dd952ec7c1648c696434994872b6020
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J. Tikkanen, Sakiko Kumata, Hisashi Oishi, Yui Watanabe, Hiromichi Niikawa, Yoshinori Okada, Takashi Hirama, Miki Akiba
Publikováno v:
BMC Pulmonary Medicine, Vol 20, Iss 1, Pp 1-8 (2020)
BMC Pulmonary Medicine
BMC Pulmonary Medicine
Background Anti-human leukocyte antigen (HLA) antibody testing was approved by the Japanese government in 2018. As such, there was no longitudinal data regarding the HLA-sensitization of lung transplant (LTX) patients in Japan. We therefore set out t
Autor:
Gregor Bond, Susanne Haindl, Sümeyra Camovic, Jeff Reeve, Konstantin Doberer, Farsad Eskandary, Markus Wahrmann, Nicolas Kozakowski, Georg A. Böhmig, Helmuth Haslacher, Jakob Mühlbacher, Heinz Regele
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Frontiers in Medicine
Frontiers in Medicine
Background: Screening for donor-specific antibodies (DSA) has limited diagnostic value in patients with late antibody-mediated rejection (ABMR). Here, we evaluated whether biomarkers reflecting microcirculation inflammation or tissue injury—as an a